Acorah Software Products - Accounts Production 19.2.350 false true 31 March 2025 1 April 2024 false 1 April 2025 31 March 2026 31 March 2026 14574453 Mr Milind Bhagwat Dr Priya Bhagwat iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 14574453 2025-03-31 14574453 2026-03-31 14574453 2025-04-01 2026-03-31 14574453 frs-core:CurrentFinancialInstruments 2026-03-31 14574453 frs-core:ComputerEquipment 2026-03-31 14574453 frs-core:ComputerEquipment 2025-04-01 2026-03-31 14574453 frs-core:ComputerEquipment 2025-03-31 14574453 frs-core:ShareCapital 2026-03-31 14574453 frs-core:RetainedEarningsAccumulatedLosses 2026-03-31 14574453 frs-bus:PrivateLimitedCompanyLtd 2025-04-01 2026-03-31 14574453 frs-bus:FilletedAccounts 2025-04-01 2026-03-31 14574453 frs-bus:SmallEntities 2025-04-01 2026-03-31 14574453 frs-bus:AuditExempt-NoAccountantsReport 2025-04-01 2026-03-31 14574453 frs-bus:SmallCompaniesRegimeForAccounts 2025-04-01 2026-03-31 14574453 frs-core:ListedExchangeTraded 2026-03-31 14574453 frs-core:ListedExchangeTraded 2025-03-31 14574453 frs-core:CostValuation frs-core:ListedExchangeTraded 2025-03-31 14574453 frs-core:AdditionsToInvestments frs-core:ListedExchangeTraded 2026-03-31 14574453 frs-core:RevaluationsIncreaseDecreaseInInvestments frs-core:ListedExchangeTraded 2026-03-31 14574453 frs-core:CostValuation frs-core:ListedExchangeTraded 2026-03-31 14574453 frs-core:ProvisionsForImpairmentInvestments frs-core:ListedExchangeTraded 2025-03-31 14574453 frs-core:ProvisionsForImpairmentInvestments frs-core:ListedExchangeTraded 2026-03-31 14574453 frs-bus:Director1 2025-04-01 2026-03-31 14574453 frs-bus:Director1 2025-03-31 14574453 frs-bus:Director1 2026-03-31 14574453 frs-bus:Director2 2025-04-01 2026-03-31 14574453 frs-countries:EnglandWales 2025-04-01 2026-03-31 14574453 2024-03-31 14574453 2025-03-31 14574453 2024-04-01 2025-03-31 14574453 frs-core:CurrentFinancialInstruments 2025-03-31 14574453 frs-core:ShareCapital 2025-03-31 14574453 frs-core:RetainedEarningsAccumulatedLosses 2025-03-31
Registered number: 14574453
Shree Medical Practice Limited
Unaudited Financial Statements
For The Year Ended 31 March 2026
Medical Finance Limited
Contents
Page
Balance Sheet 1—2
Notes to the Financial Statements 3—5
Page 1
Balance Sheet
Registered number: 14574453
2026 2025
Notes £ £ £ £
FIXED ASSETS
Tangible Assets 4 506 387
Investments 5 83,284 -
83,790 387
CURRENT ASSETS
Debtors 6 1,230 1,439
Cash at bank and in hand 83,810 106,572
85,040 108,011
Creditors: Amounts Falling Due Within One Year 7 (18,403 ) (15,687 )
NET CURRENT ASSETS (LIABILITIES) 66,637 92,324
TOTAL ASSETS LESS CURRENT LIABILITIES 150,427 92,711
NET ASSETS 150,427 92,711
CAPITAL AND RESERVES
Called up share capital 8 120 120
Profit and Loss Account 150,307 92,591
SHAREHOLDERS' FUNDS 150,427 92,711
Page 1
Page 2
For the year ending 31 March 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board
Mr Milind Bhagwat
Director
13/09/2026
The notes on pages 3 to 5 form part of these financial statements.
Page 2
Page 3
Notes to the Financial Statements
1. General Information
Shree Medical Practice Limited is a private company, limited by shares, incorporated in England & Wales, registered number 14574453 . The registered office is 1 Argyle Street, Bath, BA2 4BA.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
2.2. Turnover
Turnover represents fees receivable for private medical services provided by the company, stated net of value added tax where applicable. Turnover from the rendering of medical services is recognised in the period in which the service is performed. Fees for services performed but not invoiced or received at the balance sheet date are included in turnover and shown within debtors.
2.3. Tangible Fixed Assets and Depreciation
Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:
Computer Equipment 33.33% Straight Line Method
2.4. Taxation
Income tax expense represents the sum of the tax currently payable and deferred tax.
The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit as reported in the statement of comprehensive income because of items of income or expense that are taxable or deductible in other years and items that are never taxable or deductible. The company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period.
Deferred tax is recognised on timing differences between the carrying amounts of assets and liabilities in the financial statements and the corresponding tax bases used in the computation of taxable profit. Deferred tax liabilities are generally recognised for all taxable timing differences. Deferred tax assets are generally recognised for all deductible temporary differences to the extent that it is probable that taxable profits will be available against which those deductible timing differences can be utilised. The carrying amount of deferred tax assets is reviewed at the end of each reporting period and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered.
Deferred tax assets and liabilities are measured at the tax rates that are expected to apply in the period in which the liability is settled or the asset realised, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period. Deferred tax liabilities are presented within provisions for liabilities and deferred tax assets within debtors. The measurement of deferred tax liabilities and assets reflect the tax consequences that would follow from the manner in which the Company expects, at the end of the reporting period, to recover or settle the carrying amount of its assets and liabilities.
Current and deferred tax are recognised in profit or loss for the year, except when they relate to items that are recognised in other comprehensive income or directly in equity, in which case current and deferred tax are recognised in other comprehensive income or directly in equity respectively.
2.5. Fixed asset investments
Fixed asset investments in listed funds are measured at fair value at each reporting date, with changes in fair value recognised in profit or loss. Fair value is the quoted bid price or the fund manager's valuation at the reporting date. Income from investments retained within the investment account is included in investment income and added to the carrying amount of the investment.
3. Average Number of Employees
Average number of employees, including directors, during the year was: 2 (2025: 2)
2 2
Page 3
Page 4
4. Tangible Assets
Computer Equipment
£
Cost
As at 1 April 2025 1,374
Additions 759
As at 31 March 2026 2,133
Depreciation
As at 1 April 2025 987
Provided during the period 640
As at 31 March 2026 1,627
Net Book Value
As at 31 March 2026 506
As at 1 April 2025 387
5. Investments
Listed
£
Cost or Valuation
As at 1 April 2025 -
Additions 86,058
Revaluations (2,774 )
As at 31 March 2026 83,284
Provision
As at 1 April 2025 -
As at 31 March 2026 -
Net Book Value
As at 31 March 2026 83,284
As at 1 April 2025 -
The fixed asset investment comprises a General Investment Account of listed funds held with SEI / Fusion Wealth. Subscriptions in the year totalled £86,001, and income of £57 (interest £55.64 and dividends £1.71) was retained within the account, giving a carrying amount before revaluation of £86,058. The account was valued by the fund manager at £83,284 at 31 March 2026 and the resulting fair value loss of £2,774 has been recognised in the profit and loss account. No deferred tax asset has been recognised in respect of the fair value loss as its recovery depends on future gains on the same holdings.
6. Debtors
2026 2025
£ £
Due within one year
Trade debtors - 1,439
Other debtors 1,230 -
1,230 1,439
Page 4
Page 5
7. Creditors: Amounts Falling Due Within One Year
2026 2025
£ £
Trade creditors 1 -
Other creditors 1,717 1,784
Taxation and social security 16,685 13,903
18,403 15,687
8. Share Capital
2026 2025
£ £
Allotted, Called up and fully paid 120 120
9. Directors Advances, Credits and Guarantees
During the year the company paid personal expenses of £378 on behalf of Mr M Bhagwat. This amount was an advance within the director's current account, which remained in credit (owed to the director) throughout the year and at 31 March 2026 stood at £1,718 owed to the director. Movements on the advance were as follows:
As at 1 April 2025 Amounts advanced Amounts repaid Amounts written off As at 31 March 2026
£ £ £ £ £
Mr Milind Bhagwat - 378 - - 378
The advance was interest free and unsecured. It was repaid in full by the director on 15 September 2026.
Page 5